Codamine and Distributive shock - a phase IV clinical study of FDA data

Summary:

We study 1,467 people who take Codamine (hydrocodone bitartrate; phenylpropanolamine hydrochloride) or have Distributive shock. No report of Distributive shock is found in people who take Codamine.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What is Codamine?

Codamine has active ingredients of hydrocodone bitartrate; phenylpropanolamine hydrochloride. eHealthMe is studying from 103 Codamine users. Check the latest studies of Codamine.

What is Distributive Shock?

Distributive shock (hock caused by poor distribution of the blood flow) is found to be associated with 125 drugs and 116 conditions by eHealthMe. Check the latest studies of Distributive shock.

On Dec, 01, 2025

No report is found.

Do you take Codamine and have Distributive shock?

- Check whether Distributive shock is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Codamine:

Codamine (103 reports)

Distributive shock treatments and more:

Distributive shock (1,364 reports)

How severe was Distributive shock and when was it recovered:

Distributive shock in Codamine

Expand to all the drugs that have ingredients of hydrocodone bitartrate; phenylpropanolamine hydrochloride:

Distributive shock and drugs with ingredients of hydrocodone bitartrate; phenylpropanolamine hydrochloride

Browse all side effects of Codamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Distributive shock:

Distributive shock

Browse all the conditions that are associated with Distributive shock:

Distributive shock

How the study uses the data?

The study uses data from the FDA. It is based on hydrocodone bitartrate; phenylpropanolamine hydrochloride (the active ingredients of Codamine) and Codamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.